Skip to Main Content

Industry Resources

Information is posted on this page as a service to our readers. Medications, treatments or procedures discussed in these resources should not be used by healthcare professionals without evaluating the patient, considering risks, contraindications and manufacturers’ product information. Resources may contain promotional content. APNA is not responsible for the content of external websites. Information provided here is not a replacement for a provider’s own due diligence.



APNA Industry Sponsors


Sage Therapeutics Biogen
Sage Therapeutics | Biogen

Janssen Neuroscience

Born from the legacy of our namesake, Dr. Paul Janssen, whose discoveries transformed the treatment and care for those with serious mental illness, Janssen Neuroscience works to heal minds and restore hope for people living with serious brain disorders. We collaborate with doctors, nurses, caregivers and people living with schizophrenia and other psychiatric and neurological disorders to improve health outcomes for those we serve and advance solutions that address critical needs. Learn more about these efforts at Follow us at

Resources from Janssen:

Neurocrine Biosciences
Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs, but few options. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine, and neuropsychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington’s disease, Parkinson’s disease, endometriosis*, and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid-to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science. For more information, visit, and follow the company on LinkedInTwitter, and Facebook. (*in collaboration with AbbVie)

As a member of APNA, the field medical affairs team at Neurocrine Biosciences is pleased to provide educational resources to assist in your clinical assessment of drug-induced abnormal movements. These abnormal movements may be observed in patients in both inpatient and outpatient neuro settings. Recognition and appropriate differentiation of drug-induced movement disorders (DIMDs), including akathisia, drug-induced parkinsonism (DIP), dystonia, and tardive dyskinesia (TD) are imperative to appropriate treatment since improper treatment may make DIMDs worse.

Below are links to several literature-supported resources that may assist in developing your assessment skills. If you have additional questions or seek additional information, please reach out to your respective Clinical Practice Liaison.

Resources from Neurocrine Biosciences: 

Noven Pharmaceuticals
Noven Pharmaceuticals, Inc. is a dynamic specialty pharmaceutical company engaged in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products. We are committed to developing and offering pharmaceutical products that meaningfully benefit patients, with a commitment to advancing patient care through transdermal drug delivery.

Industry Opportunities

APNA Conferences
We invite you to join is as an exhibitor or sponsor to promote your organization during one of our conferences. We typically have two conferences each year: our APNA Clinical Psychopharmacology Institute (CPI) in June, and the APNA Annual Conference in the Fall. We offer opportunities for product theaters, symposia, exhibits, sponsorships, and advertising. For our Annual Conference we offer the opportunity to submit an abstract for possible presentation. The call for abstracts is posted and sent each Winter and abstracts are selected and confirmed in the Spring. Product theater and symposia offerings are posted in the Fall and typically sell out in mid to late January.

We have multiple opportunities for advertising including APNA News, our electronic newsletter, Member Bridge, our members-only community site, and the Journal of the American Psychiatric Nurses Association (JAPNA). Click here for more information.

Industry Partner Program
Our Industry Partner Program is a high-profile, year-round sponsorship with exclusive benefits to connect with the APNA community at-large, and with APNA leadership.

Contact Elsa Cannon, Meetings and Sponsorships Manager, at or 571-533-1741 for more information about any of the above industry opportunities.